brain neoplasm: A neoplasm (disease) that involves the brain.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
217 |
4. Check minimum number of eventsNone |
217 |
5. Include endpointsNone |
217 |
6. Filter based on genotype QC (FinnGen only) |
211 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D33
- Name in latin
- Neoplasma benignum cerebri infratentoriale
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Brain, infratentorial
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1554 | 828 | 719 |
| Only index persons | 1386 | 743 | 643 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 44.15 | 46.77 | 40.95 |
| Only index persons | 43.19 | 45.75 | 40.23 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 211 | 128 | 83 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | 48.22 | 47.09 | 49.98 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 217
- Matched controls
- 2170
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
26.9
140.5
134
123
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
280.7
117.8
111
8
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
52.8
78.1
46
11
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
70.8
64
*
D33.14
ICD-10 Finland
Hemangioblastoma and cerebellum
+∞
61.4
56
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
18.1
51.7
45
31
D33.15
ICD-10 Finland
Another benign tumor of the cerebellum
+∞
51.1
47
*
9161/1-C71.6
ICD-O-3
Hemangioblastoma of cerebellum, NOS
+∞
46.6
43
*
D33.11
ICD-10 Finland
Brain stem
+∞
43.2
40
*
D33.12
ICD-10 Finland
Cerebellum
+∞
37.6
35
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
138.3
33.8
35
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.8
32.6
80
198
C71.60
ICD-10 Finland
Malignant tumor of cerebellum without histology
+∞
31.0
29
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.4
28.6
57
115
D33.1
ICD-10 Finland
Benign neoplasm: Brain, infratentorial
+∞
25.5
24
*
AA1AD
NOMESCO Finland
CT of head and brain
4.3
24.3
98
351
H02AB02
ATC
dexamethasone; systemic
4.8
20.7
56
146
XA800
NOMESCO Finland
Neuropsychological investigation
6.9
19.2
32
53
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
26.6
19.2
26
11
9421/1-C71.6
ICD-O-3
Pilocytic astrocytoma of cerebellum, NOS
+∞
19.0
18
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
97.7
16.8
18
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
15.8
15
*
H53.2
ICD-10 Finland
Diplopia
7.7
15.6
23
33
D33.17
ICD-10 Finland
Fourth ventricle
+∞
14.7
14
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.4
14.0
66
250
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
148.9
13.6
14
*
XCK00
NOMESCO Finland
Perimetry
5.1
13.3
30
66
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
13.3
84
376
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
26.2
12.7
17
7
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
+∞
12.6
12
*
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
+∞
12.6
12
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.5
12.6
51
174
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
137.6
12.6
13
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
22.9
12.2
17
8
AAF00
NOMESCO Finland
Ventriculostomy
49.6
12.0
14
*
R51.80
ICD-10 Finland
Headache
3.1
11.7
63
255
ZXD05
NOMESCO Finland
Urgent procedure
2.7
11.4
88
432
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
19.1
10.9
16
9
G93.0
ICD-10 Finland
Cerebral cysts
63.2
10.7
12
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.6
10.5
39
125
D33.42
ICD-10 Finland
Hemangioblastoma of the spinal cord
+∞
10.5
10
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
10.2
65
287
G91.0
ICD-10 Finland
Communicating hydrocephalus
57.6
9.7
11
*
ZXC95
NOMESCO Finland
Use of surgical navigator
22.9
9.5
13
6
D32.05
ICD-10 Finland
Cerebral meninges
+∞
9.4
9
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
13.3
9.0
15
12
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.5
9.0
23
56
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
28.8
8.6
11
*
D33.30
ICD-10 Finland
Acoustic neuroma
28.8
8.6
11
*
N76
ICPC
Neoplasm nervous system unspecified
93.5
8.5
9
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
+∞
8.4
8
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.1
8.0
23
61
ZXD35
NOMESCO Finland
Usual procedure
6.6
7.7
19
31
TAB00
NOMESCO Finland
Lumbar puncture
4.1
7.7
22
58
WX882
NOMESCO Finland
High dependency care
6.9
7.6
18
28
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
14.0
7.5
12
9
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
14.0
7.5
12
9
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
+∞
7.3
7
*
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
+∞
7.3
7
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
+∞
7.3
7
*
Z98.2
ICD-10 Finland
Presence of cerebrospinal fluid drainage device
+∞
7.3
7
*
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
+∞
7.3
7
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
16.5
7.3
11
7
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
31.1
7.2
9
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
31.1
7.2
9
*
N03AX14
ATC
levetiracetam; systemic
8.0
7.0
15
20
WF002
NOMESCO Finland
Radical radiotherapy
4.4
7.0
18
44
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
6.9
88
519
AA1BD
NOMESCO Finland
Extensive CT of head and brain
7.6
6.8
15
21
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
23.4
6.7
9
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.3
6.7
26
85
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
6.5
44
196
Z2445
NOMESCO Finland
Psychologist
3.4
6.5
24
76
9421/1-C71.9
ICD-O-3
Pilocytic astrocytoma of brain, NOS
71.9
6.5
7
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
6.4
92
564
R42
ICD-10 Finland
Dizziness and giddiness
2.3
6.3
57
291
C71.69
ICD-10 Finland
Malignant tumor of the cerebellum other or unspecified histology
+∞
6.3
6
*
AAF50
NOMESCO Finland
Third ventriculostomy
+∞
6.3
6
*
C71.6
ICD-10 Finland
Malignant neoplasm: Cerebellum
+∞
6.3
6
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.2
6.0
16
40
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
29
10
33.18
22.52
2.2
2.0
—
—
—
0
0
54
175
3.78
14.56
7.1
11.0
0.65
1.29
mmol/l
0.56
41
144
132
775
2.80
12.20
7.1
7.6
1.20
1.22
mmol/l
1.86
123
713
20
18
12.11
11.31
3.3
1.2
—
—
—
0
0
135
845
2.58
10.30
5.6
8.3
1.21
1.22
mmol/l
1.70
122
735
40
141
3.25
9.24
5.6
10.5
23.91
24.89
mmol/l
1.30
40
141
153
1049
2.55
9.13
6.0
5.5
6.43
6.53
mmol/l
0.25
148
962
14
10
14.86
8.82
2.8
1.2
—
—
—
0
0
79
419
2.39
8.24
2.6
2.4
—
—
—
0
0
20
47
4.59
8.13
2.3
2.2
24.31
3.45
e6/l
0.61
13
38
20
47
4.59
8.13
2.4
2.3
95.69
268.20
e6/l
0.55
13
41
17
22
8.28
8.05
4.2
3.5
1.45
3.21
nmol/l
1.43
17
22
113
756
2.03
6.15
9.6
10.6
1.22
1.21
inr
0.02
27
238
119
823
1.99
5.77
2.7
2.7
—
—
—
0
0
10
10
10.41
5.59
2.2
4.6
58.70
101.70
nmol/l
—
10
10
42
209
2.25
4.84
6.6
8.3
104.98
104.12
mmol/l
0.70
42
209
102
717
1.80
4.30
4.0
5.5
36.81
35.95
g/l
0.87
93
682
202
1825
2.55
3.22
18.4
15.4
3.96
3.96
mmol/l
0.04
197
1765
201
1819
2.42
3.06
18.9
15.3
139.66
139.66
mmol/l
0.00
196
1764
48
304
1.74
2.73
1.9
1.6
942.22
1228.28
nmol/l
1.26
37
227
85
626
1.59
2.70
2.9
3.7
17.69
38.26
ng/l
1.86
51
406
116
919
1.56
2.68
5.5
7.0
10.28
12.61
umol/l
1.56
106
872
33
190
1.87
2.56
5.3
7.1
—
—
—
0
0
80
590
1.56
2.49
3.7
3.5
2.36
2.36
mmol/l
0.12
64
518
64
451
1.59
2.41
2.0
2.1
3.25
2.97
mg/l
0.42
53
395
84
639
1.51
2.23
3.3
3.0
—
—
—
0
0
5
9
5.65
2.22
1.2
1.1
—
—
—
0
0
7
21
3.41
1.98
1.7
1.5
2.34
2.24
ug/l
—
7
16
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
11
4.62
1.95
1.4
1.2
—
—
—
0
0
5
11
4.62
1.95
1.2
1.1
—
—
—
0
0
44
302
1.57
1.83
3.0
2.8
2.41
2.44
mmol/l
1.92
37
260
42
286
1.58
1.80
2.0
5.4
0.81
0.81
mmol/l
0.04
37
271
45
314
1.55
1.74
3.1
2.8
0.76
0.98
e6/l
0.30
31
170
15
75
2.07
1.74
1.7
1.5
254.73
340.35
mu/l
0.76
15
68
68
519
1.45
1.71
3.5
3.0
0.18
0.34
e6/l
0.83
58
382
68
530
1.41
1.51
2.0
2.5
51.74
54.32
u/l
0.37
61
496
81
655
1.38
1.44
2.3
1.9
99.13
96.96
pmol/l
0.15
50
315
31
208
1.57
1.43
4.0
4.3
31.00
32.62
%
0.40
21
136
154
1384
1.39
1.38
4.3
3.9
14.62
14.73
pmol/l
0.18
138
1252
40
288
1.48
1.34
3.4
3.0
2.80
2.43
e6/l
0.07
25
146
98
834
1.32
1.21
2.4
2.7
128.67
97.52
ug/l
0.57
88
772
89
752
1.31
1.14
2.6
2.5
74.57
76.47
nmol/l
0.24
81
672
19
120
1.64
1.13
3.6
3.1
75.17
67.53
ml/min/173m2
—
6
53
193
1830
1.49
1.05
16.5
13.5
20.88
21.50
mg/l
0.12
171
1435
176
1644
1.37
1.03
13.3
12.2
89.01
85.38
ml/min/173m2
1.46
152
1327
35
261
1.41
1.00
2.8
2.9
1.01
0.75
ug/l
0.80
22
165
148
1360
1.28
0.91
7.2
7.4
76.88
81.71
u/l
0.85
139
1267
43
339
1.33
0.88
1.7
1.7
447.06
481.64
pmol/l
0.36
34
293
34
262
1.35
0.81
1.5
1.9
—
—
—
0
0
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
175
1654
1.30
0.78
5.3
4.6
1.67
2.60
mu/l
0.70
160
1510
11
172
0.62
0.77
1.2
1.7
—
—
—
0
0
165
1739
0.79
0.75
4.9
4.6
2.83
2.76
mmol/l
0.48
151
1610
43
348
1.29
0.74
3.8
4.6
22.45
21.05
%
0.29
22
160
48
395
1.28
0.73
3.6
3.8
1.02
1.02
kg/l
0.06
11
52
10
60
1.70
0.73
1.4
1.6
—
—
—
0
0
7
40
1.77
0.72
1.1
1.5
—
—
—
0
0
7
40
1.77
0.72
1.3
1.1
—
—
—
0
0
25
188
1.37
0.70
1.5
1.7
—
—
—
0
0
33
411
0.77
0.68
2.0
2.1
0.66
1.21
mg/l
2.20
27
316
163
1712
0.81
0.64
4.3
4.2
4.74
4.66
mmol/l
0.48
148
1599
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
162
1699
0.82
0.60
4.3
4.2
1.46
1.49
mmol/l
0.23
148
1576
120
1287
0.85
0.55
3.2
3.3
—
—
—
0
0
24
190
1.30
0.50
1.5
1.8
—
—
—
0
0
7
108
0.64
0.50
1.1
1.0
—
—
—
0
0
7
50
1.41
0.45
1.0
2.2
—
—
—
0
0
36
305
1.22
0.44
3.5
3.7
39.04
132.59
ng/l
1.45
26
233
12
87
1.40
0.43
1.8
1.6
—
—
—
0
0
8
57
1.42
0.42
2.0
2.0
—
—
—
0
0
0
15
0.00
0.41
0.0
3.9
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.8
—
3.16
—
0
16
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
8
61
1.32
0.40
1.9
2.2
—
—
—
0
0
5
35
1.44
0.39
1.2
1.3
—
—
—
0
0
5
35
1.44
0.39
1.2
1.7
—
—
—
0
0
5
35
1.44
0.39
1.2
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
9
66
1.38
0.39
1.0
1.1
—
—
—
0
0
5
36
1.40
0.38
1.4
1.4
—
—
—
0
0
18
145
1.26
0.35
3.7
5.2
2.34
1.43
mmol/l
0.50
13
101
6
46
1.31
0.33
1.0
1.0
—
9.86
—
0
9
10
132
0.75
0.33
1.3
1.3
178.40
118.02
iu/ml
—
5
53
139
1332
1.12
0.31
4.1
4.0
11.59
10.83
mm/h
0.23
126
1219
39
438
0.87
0.31
1.8
2.8
321.82
7593.12
umol/l
2.24
33
380
36
317
1.16
0.31
1.3
1.4
—
—
—
0
0
9
74
1.23
0.25
1.3
2.0
—
—
—
0
0
12
96
1.26
0.25
1.6
1.2
—
—
—
0
0
93
884
1.09
0.23
3.8
3.6
0.00
0.00
estimate
-0.00
14
192
28
249
1.14
0.22
1.9
2.5
2.38
2.42
g/l
0.11
23
228
8
102
0.78
0.21
1.8
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
3.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
3.8
—
—
—
0
0
0
11
0.00
0.21
0.0
2.4
—
685.45
—
0
11
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
156.43
—
0
10
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
91.14
—
0
7
0
12
0.00
0.21
0.0
1.0
—
100.29
—
0
7
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
12
0.00
0.21
0.0
1.0
—
120.50
—
0
12
13
155
0.83
0.21
2.3
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
116
1117
1.08
0.20
7.0
10.1
4.20
3.95
e9/l
0.55
99
973
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
7
61
1.15
0.17
1.1
2.3
—
—
—
0
0
120
1233
0.94
0.14
3.6
3.2
50.02
42.78
u/l
0.48
111
1166
14
124
1.14
0.11
1.2
1.5
—
—
—
0
0
32
299
1.08
0.11
1.3
1.3
12.35
30.24
iu/ml
2.07
11
105
46
437
1.07
0.11
2.1
3.5
436.74
1218.70
ng/l
2.60
35
370
31
290
1.08
0.11
1.4
1.3
8.81
8.21
u/ml
0.03
14
118
5
48
1.04
0.09
1.2
1.5
—
—
—
0
0
6
54
1.11
0.09
1.5
1.4
—
—
—
0
0
162
1640
0.95
0.08
3.8
3.8
1.29
1.26
mmol/l
0.27
147
1513
5
63
0.79
0.08
1.4
1.5
—
—
—
0
0
44
459
0.95
0.08
3.2
3.8
1.96
8.78
mg/mmol
3.95
27
287
7
64
1.10
0.08
1.1
1.2
—
—
—
0
0
7
65
1.08
0.08
1.0
1.1
—
—
—
0
0
91
890
1.04
0.07
5.7
4.9
0.00
0.00
estimate
-0.00
13
183
170
1685
1.04
0.05
4.4
4.1
5.61
5.84
mmol/l
2.00
156
1544
71
695
1.03
0.05
3.8
3.6
—
—
—
0
0
31
300
1.04
0.03
2.5
2.3
—
—
—
0
0
204
2033
1.06
0.01
24.3
19.8
262.40
252.57
e9/l
1.40
198
1980
204
2033
1.06
0.01
24.4
20.0
40.05
40.17
%
0.13
189
1933
48
488
0.98
0.01
3.7
3.9
0.00
0.00
estimate
-0.00
12
177
17
164
1.04
0.00
3.1
3.4
—
—
—
0
0
11
112
0.98
0.00
1.0
1.3
—
—
—
0
0
42
419
1.00
0.00
1.8
1.6
—
—
—
0
0
46
461
1.00
0.00
1.2
1.3
5.55
1.37
u/ml
0.46
12
120
28
275
1.02
0.00
2.3
2.2
—
—
—
0
0
90
903
0.99
0.00
4.2
3.7
0.00
0.00
estimate
-0.00
13
177
204
2035
1.04
0.00
24.2
19.8
4.51
4.50
e12/l
0.08
198
1978
192
1922
0.99
0.00
10.3
10.1
25.86
25.59
u/l
0.10
185
1858
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
158
1580
1.00
-0.00
5.5
5.2
37.28
39.27
mmol/mol
2.59
146
1484
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
57
0.87
-0.00
3.2
2.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
70
1.00
-0.00
1.7
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.5
—
136.38
—
0
8
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
7.0
—
208.33
—
0
6
0
5
0.00
-0.00
0.0
2.6
—
25.80
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
7.57
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
-0.00
1.3
1.1
—
—
—
0
0
13
130
1.00
-0.00
2.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_BRAIN_INFRATENT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BRAIN_INFRATENT | 1.861 [1.47, 2.35] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.201 |
During the follow-up period (1.1.1998 — 31.12.2019), 125 out of 692 females with CD2_BENIGN_BRAIN_INFRATENT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BRAIN_INFRATENT | 2.417 [1.8, 3.24] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.089 |
During the follow-up period (1.1.1998 — 31.12.2019), 122 out of 603 males with CD2_BENIGN_BRAIN_INFRATENT died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_BRAIN_INFRATENT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.215% | 0.496% |
| 5 | 1.161% | 3.052% |
| 10 | 2.919% | 7.476% |
| 15 | 5.319% | 14.591% |
| 20 | 9.131% | 24.239% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BRAIN_INFRATENT – Benign neoplasm: Brain, infratentorial
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data